Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lord Jones
- Development stage
- Unknown
- Lead developer
- Cronos Group
- Modality
- Small Molecules
01
Overview
Lord Jones is a premium brand of hemp-derived cannabidiol (CBD) products, including topicals, edibles, and tinctures, designed for wellness and therapeutic applications. Originally founded by Cindy Capobianco and Robert Rosenheck and later acquired by Cronos Group in 2019, the brand is positioned in the luxury market and focuses on high-quality, broad-spectrum CBD formulations. The primary active ingredient, CBD, is a non-psychoactive cannabinoid that interacts with the endocannabinoid system (ECS) and various non-cannabinoid receptors to provide analgesic, anti-inflammatory, and anxiolytic effects. While Lord Jones products are not FDA-approved pharmaceuticals for specific medical conditions, they are widely marketed and used for managing pain, anxiety, inflammation, and skin conditions. In late 2023, Cronos Group announced a strategic pivot for the brand, including the launch of THC-containing products in the Canadian market while maintaining its CBD-focused line in the United States.
- Brand names
- Lord Jones
- Other names
- Lord Jones CBDHigh CBD Formula Body Lotion
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))TRPV1 (Transient receptor potential cation channel subfamily V member 1)CB2 (Cannabinoid receptor 2)
Beyond the preview
Go deeper on Lord Jones.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lord Jones.